# The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19

> **NCT05113810** · PHASE2 · UNKNOWN · sponsor: **Ministry of Health Jordan** · enrollment: 110 (estimated)

## Conditions studied

- 2019 Novel Coronavirus

## Interventions

- **DRUG:** HCQ01
- **OTHER:** standard of care (SOC) for COVID-19

## Key facts

- **NCT ID:** NCT05113810
- **Lead sponsor:** Ministry of Health Jordan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-20
- **Primary completion:** 2022-07-20
- **Final completion:** 2022-07-20
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2022-03-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05113810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05113810, "The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05113810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*